Baird Financial Group Inc. grew its position in Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) by 35.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,751 shares of the company’s stock after purchasing an additional 2,825 shares during the period. Baird Financial Group Inc.’s holdings in Surgery Partners were worth $311,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. Cannell & Co. lifted its position in Surgery Partners by 59.9% during the second quarter. Cannell & Co. now owns 361,245 shares of the company’s stock valued at $10,447,000 after buying an additional 135,270 shares in the last quarter. Level Four Advisory Services LLC acquired a new position in shares of Surgery Partners during the 2nd quarter valued at $584,000. Envestnet Asset Management Inc. lifted its holdings in shares of Surgery Partners by 11.0% during the 2nd quarter. Envestnet Asset Management Inc. now owns 13,113 shares of the company’s stock valued at $379,000 after acquiring an additional 1,298 shares in the last quarter. Wolverine Asset Management LLC boosted its position in Surgery Partners by 2.5% during the 2nd quarter. Wolverine Asset Management LLC now owns 16,541 shares of the company’s stock worth $478,000 after purchasing an additional 400 shares during the period. Finally, SG Americas Securities LLC purchased a new position in Surgery Partners in the second quarter valued at about $108,000.
Surgery Partners Trading Up 2.3 %
NASDAQ SGRY opened at $25.74 on Wednesday. The company has a market capitalization of $2.32 billion, a price-to-earnings ratio of -73.54 and a beta of 2.82. The company has a debt-to-equity ratio of 1.47, a current ratio of 1.18 and a quick ratio of 1.07. Surgery Partners, Inc. has a 12 month low of $20.46 and a 12 month high of $63.87. The company’s fifty day moving average price is $26.10 and its two-hundred day moving average price is $31.67.
Insider Transactions at Surgery Partners
Analyst Upgrades and Downgrades
Several brokerages have recently weighed in on SGRY. StockNews.com downgraded Surgery Partners from a “hold” rating to a “sell” rating in a research report on Saturday, November 5th. Cowen lowered their price objective on shares of Surgery Partners to $35.00 in a research report on Wednesday, November 16th. Royal Bank of Canada reduced their target price on shares of Surgery Partners from $62.00 to $58.00 and set an “outperform” rating on the stock in a research report on Thursday, November 10th. Stifel Nicolaus lowered their price target on shares of Surgery Partners from $44.00 to $36.00 in a report on Tuesday. Finally, Citigroup cut their price objective on shares of Surgery Partners from $49.00 to $38.00 and set a “buy” rating on the stock in a report on Wednesday, November 9th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, Surgery Partners currently has a consensus rating of “Moderate Buy” and an average price target of $49.22.
About Surgery Partners
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
- Get a free copy of the StockNews.com research report on Surgery Partners (SGRY)
- After Nixing its 13% Dividend, Is Lumen Technologies Okay To Own?
- The Sell-Side Caps Gains In Dick’s Sporting Goods
- Cisco Systems Hopes Restructuring Cuts Costs to Drive Revenue
- Stock-ing Stuffers: 3 Attractive Stocks Trading Around $10
- Want to Get a 10% Dividend Yield, Look Here
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.